cro.directory
Home
MMS Holdings logo

MMS Holdings

Data-focused CRO turning complex data into clear decisions for regulatory success.

Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.

Phases

Indications / Therapeutic Areas

Services

Modalities

About this organization

Overview

MMS Holdings is a global, data-focused Clinical Research Organization (CRO) founded in 2006 by Dr. Uma Sharma. With more than 1,000 colleagues worldwide and a presence spanning four continents, MMS supports pharmaceutical, biotech, and medical device sponsors from pre-IND through marketing authorization and post-approval.

Core Services

Biometrics & Data Science

  • Full-service biometrics management: CRF design, data build, CSR delivery
  • Statistical consulting and biostatistics support
  • Data Monitoring Committees (DMCs)
  • Data management and statistical programming
  • Data science and risk-based data management

Regulatory & Medical Writing

  • Regulatory strategy consulting
  • Regulatory affairs management
  • Expedited regulatory pathways
  • Global regulatory operations
  • Medical writing and quality control
  • Proven track record: zero refusals to file; 50+ marketing applications in past five years

Safety & Risk Management

  • Comprehensive pharmacovigilance from Phase 1 through post-approval
  • Drug safety and PV services
  • Compliance and auditing
  • REMS solutions

Therapeutic Expertise

  • Specialized knowledge in rare diseases, psychedelics, oncology, radiopharmaceuticals, and CNS disorders
  • Support for industry-first and well-researched indications

Technology & Innovation

  • Datacise® suite: IDMC management, safety signal detection, data flow management, near real-time data status
  • Automatiqc®, PVantage®, KerusCloud® platforms
  • AI-driven trial design and analysis capabilities
  • 2025 acquisition of Exploristics strengthened simulation-driven development and trial design

Engagement Models

  • Full-Service Outsourcing (FSO) and Functional Service Provider (FSP) models available
  • Flexible, scalable FSP approach for long- and short-term strategic goals
  • CRO transition & rescue solutions

Recognition & Awards

  • Best Specialist CRO – Scrip Awards
  • Best Data-Focused CRO – GHP Global Excellence Awards
  • Excellence in Client Service and Partnership – Fierce CRO Awards
  • Data Science Solution of the Year – Data Breakthrough Awards (Datacise®)
  • Top Workplace (US and Michigan, multiple years)
  • Certified Great Place to Work (India and global regions)

Notable Engagements

  • TOGETHER Trial: EDC system designed and maintained by MMS; won Society for Clinical Trial's Trial of the Year Award
  • Friends of Cancer Research: Supporting development of decision frameworks for interim overall survival interpretation in oncology
  • Gates Ventures / Johnson & Johnson / AD Data Initiative: Data intake, harmonization, and anonymization for 250 million protein measurements across 35,000 biosamples in neurodegenerative disease research

Locations

  • Global headquarters

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/mmsholdings.md